205 related articles for article (PubMed ID: 33126827)
1. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours.
Fazal Z; Singh R; Fang F; Bikorimana E; Baldwin H; Corbet A; Tomlin M; Yerby C; Adra N; Albany C; Lee S; Freemantle SJ; Nephew KP; Christensen BC; Spinella MJ
Epigenetics; 2021 Oct; 16(10):1071-1084. PubMed ID: 33126827
[TBL] [Abstract][Full Text] [Related]
2. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Lobo J; Constâncio V; Leite-Silva P; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
Clin Epigenetics; 2021 Apr; 13(1):70. PubMed ID: 33823933
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy.
Singh R; Fazal Z; Bikorimana E; Boyd RI; Yerby C; Tomlin M; Baldwin H; Shokry D; Corbet AK; Shahid K; Hattab A; Freemantle SJ; Spinella MJ
Mol Oncol; 2022 Feb; 16(3):683-698. PubMed ID: 34482638
[TBL] [Abstract][Full Text] [Related]
4. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
[TBL] [Abstract][Full Text] [Related]
5. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
6. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
7. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
9. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin.
Kawakami T; Zhang C; Okada Y; Okamoto K
Oncogene; 2006 Jun; 25(23):3225-36. PubMed ID: 16434968
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic profile of testicular germ cell tumours.
Okamoto K; Kawakami T
Int J Androl; 2007 Aug; 30(4):385-92; discussion 392. PubMed ID: 17521367
[TBL] [Abstract][Full Text] [Related]
11. Association Between
Markulin D; Vojta A; Samaržija I; Gamulin M; Bečeheli I; Jukić I; Maglov Č; Zoldoš V; Fučić A
Cancer Genomics Proteomics; 2017; 14(5):363-372. PubMed ID: 28871003
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors.
Kempkensteffen C; Christoph F; Weikert S; Krause H; Köllermann J; Schostak M; Miller K; Schrader M
J Cancer Res Clin Oncol; 2006 Dec; 132(12):765-70. PubMed ID: 16810501
[TBL] [Abstract][Full Text] [Related]
13. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors.
Killian JK; Dorssers LC; Trabert B; Gillis AJ; Cook MB; Wang Y; Waterfall JJ; Stevenson H; Smith WI; Noyes N; Retnakumar P; Stoop JH; Oosterhuis JW; Meltzer PS; McGlynn KA; Looijenga LH
Genome Res; 2016 Nov; 26(11):1490-1504. PubMed ID: 27803193
[TBL] [Abstract][Full Text] [Related]
14. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas.
Kawakami T; Okamoto K; Kataoka A; Koizumi S; Iwaki H; Sugihara H; Reeve AE; Ogawa O; Okada Y
Genes Chromosomes Cancer; 2003 Sep; 38(1):97-101. PubMed ID: 12874790
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors.
Singh R; Fazal Z; Corbet AK; Bikorimana E; Rodriguez JC; Khan EM; Shahid K; Freemantle SJ; Spinella MJ
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31181810
[TBL] [Abstract][Full Text] [Related]
16. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.
Beyrouthy MJ; Garner KM; Hever MP; Freemantle SJ; Eastman A; Dmitrovsky E; Spinella MJ
Cancer Res; 2009 Dec; 69(24):9360-6. PubMed ID: 19951990
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.
Lobo J; Constâncio V; Guimarães-Teixeira C; Leite-Silva P; Miranda-Gonçalves V; Sequeira JP; Pistoni L; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
Mol Oncol; 2021 Apr; 15(4):846-865. PubMed ID: 33513287
[TBL] [Abstract][Full Text] [Related]
18. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor.
Kitayama S; Ikeda K; Sato W; Takeshita H; Kawakami S; Inoue S; Horie K
Sci Rep; 2022 Nov; 12(1):18423. PubMed ID: 36319719
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
20. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
